NexImmune
Mr. Stover brings over 15 years of accounting, finance, and audit experience serving various life science companies in the U.S. and internationally. Before joining NexImmune, he served as Executive Director, Corporate Controller at Autolus Therapeutics Plc. in London. Mr. Stover served as Director, Financial Reporting for Sucampo Pharmaceuticals, Inc and as Associate Director of External Reporting & Technical Accounting at Iridium Communications Inc. He honed his accounting experience serving as a Senior Manager of Ernst & Young LLP advising U.S. and international companies. Mr. Stover earned a B.A. in Economics from Wittenberg University, a MPA from American University, and is a licensed CPA.
This person is not in any offices
NexImmune
NexImmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary AIM™ technology.